CRO CONSULTING SERVICES

Physiogenex provides unique CRO consulting services in order to help our clients in their drug development strategy. This service helps to reduce time and cost, and ensures the successful launch of new therapies. We offer over 15 years of experience in developing drugs targeting obesity, type 2 diabetes, dyslipidaemia, inflammation, diabetic nephropathy, NASH/MASH, fibrosis and cardiovascular complications.

For each consulting request, we provide a customized and personalized service with:

• A complete and topic-related literature search,
• A thorough analysis of available data on the drug or therapeutic target,
• Our interpretation and recommendations for a successful drug development

The CRO consulting services include a continuous interaction between Physiogenex’s experts and our clients with phone conferences, on-site face-to-face meetings, and a complete consulting report including scientific references.